THROMBOSIS
Alembic Pharma gets USFDA nod for Dabigatran Etexilate capsules
Alembic Pharmaceuticals Ltd received final approval from the US health regulator for generic Dabigatran Etexilate capsules 75 mg and 150 mg to reduce stroke and blood clots in adults with a specific medical condition.
Artificial sweetners in chewing gum and even toothpaste can give you blood clots, heart attacks or stroke: Study
Artificial sweeteners, particularly xylitol, may pose health risks by affecting platelets and blood clotting, leading to cardiovascular events. Caution is advised, with recommendations for natural sweeteners and occasional use of xylitol products for those at risk.
Good shot, bad shot: What you need to know about Covishield issue
Covishield Side Effects: Controversies surrounding vaccine side-effects persist despite Covid-19 waning. Covishield, developed by AstraZeneca and Oxford University, faces scrutiny in India following reports of rare side effects. Legal battles and demands for compensation have emerged as families of alleged victims seek justice. Experts stress the importance of understanding risks versus benefits in vaccine administration.
Clot in blood vessels occurs in rare cases with certain vaccines: Medical Expert amid reports over AstraZeneca
Dr. Rajeev Jayadevan, Co-Chairman of the National Indian Medical Association (IMA) Covid Task Force in Kerala, explains that Thrombosis Thrombocytopenia Syndrome (TTS), involving blood clots in rare cases, has been associated with certain vaccines, including adenovirus vector vaccines like Covishield. Despite the rarity, such events have been highlighted in reports, amidst recent admission by AstraZeneca regarding TTS risks. The WHO has also issued guidance on managing TTS cases following COVID-19 vaccination.
Covishield side effects: Doctors' group urges govt to review all Covid vaccines
AstraZeneca acknowledges Covid vaccine risk. Doctors express Covishield concerns. Emphasis on active surveillance. Urgency for investigation, fast track courts, compensation for vaccine injuries.
BJP has put lives of its countrymen at risk: SP chief Akhilesh Yadav on global withdrawal of Covishield
Akhilesh Yadav slams BJP for risking lives with AstraZeneca's global Covishield withdrawal due to excess supply. How will dangerous vaccine return from recipients? Rare side effect TTS disclosed.
Serum Institute says it already disclosed 'all side effects' of Covishield, clarifies it stopped making the vaccine in 2021
The Serum Institute of India has stopped manufacturing and providing additional doses of the Covishield vaccine due to concerns about its side effects. AstraZeneca has also withdrawn its Vaxzervria vaccine and marketing authorizations within Europe. The UK-based pharmaceutical company collaborated with the Serum Institute of India to provide the vaccine to the Indian government. Families of individuals who experienced adverse effects are pursuing legal action against AstraZeneca and the Serum Institute of India.
Disclosed all information on Covishield’s side effects in 2021, says SII
The Serum Institute of India (SII) has stated that the safety of vaccines remains "paramount" and that all information about the side effects of its Covishield vaccine against Covid-19 was disclosed in its packaging insert in 2021. The statement comes after a group of parents whose children died during the pandemic filed a case against the company. SII manufactured and supplied the vaccine under license from AstraZeneca, which admitted in court that the vaccine could cause a rare side effect.
Covishield deaths could be more than estimates: Parents
SII discloses TTS side-effects. Venugopalan Govindan raises Covishield concerns. Parents plan case against SII. AstraZeneca withdraws VaxAstraZeneca due to mutant variant strains.
Covishield Side Effects: What's TTS syndrome, symptoms, and danger signs you shouldn't ignore
Covishield TTS: AstraZeneca has acknowledged the potential TTS side effects from its COVID-19 vaccine Covishield, used widely in India. TTS, Thrombosis with Thrombocytopenia Syndrome, is rare but serious, marked by blood clots and low platelet levels. Symptoms include headaches, blurred vision, and chest pain. Dr. Jayadevan emphasizes awareness, stressing early treatment for effective management. AstraZeneca's admission follows reports of TTS linked to adenovirus vector vaccines.
Every vaccine carries a risk. If benefits outweigh it, you use it: Dr Shahid Jameel
In India, where the majority of people were administered Covishield the news of a lawsuit against AstraZeneca in the UK over Covid vaccination has caused concern. Dr Shahid Jameel, virologist and research fellow at Green Templeton College,University of Oxford, tells Indulekha Aravind that there is no cause for worry as benefits far outweigh risks.
Covishield Vaccine Row: PM Modi's image no more on your vaccination certificate? Here's why
Covishield Vaccine: The recent admission by vaccine maker AstraZeneca in a UK court has sparked discussions about the potential side effect of Thrombosis with Thrombocytopenia Syndrome (TTS) in Covishield, leading many in India to reexamine their vaccination certificates.
Covishield Vaccine Case: AstraZeneca expresses 'sympathy' for those who lost loved ones
Covishield Vaccine Row: Following AstraZeneca's acknowledgment of a rare side effect associated with its COVID-19 vaccine, known as Covishield in India, the UK pharmaceutical giant extended sympathy to those impacted. Reaffirming its dedication to patient safety amidst concerns about potential rare side effects, AstraZeneca emphasised the vaccine's overall safety profile. The company underscored the stringent standards of regulatory authorities to ensure the safe use of medicines, including vaccines. AstraZeneca highlighted the extensive clinical trial data and real-world evidence consistently supporting the safety and efficacy of the vaccine.
Amid Covishield row, what WHO says on side-effects from Covid vaccine? Should you be worried?
Recent revelations by pharmaceutical company AstraZeneca have brought Covid vaccines back into the spotlight, with acknowledgment that its AstraZeneca-Oxford vaccine can, in very rare instances, lead to Thrombosis Thrombocytopenia Syndrome (TTS)," a condition involving the formation of blood clots in blood vessels. Despite these rare occurrences, the pharmaceutical firm maintains that extensive clinical trial data and real-world evidence consistently support the safety and effectiveness of the vaccine.
AstraZeneca acknowledges its covid vaccine, Covishield, can lead to rare blood clot side effects; Here's what we know
Covishield Covid Vaccine: The Covishield COVID-19 vaccine, developed by AstraZeneca in partnership with the University of Oxford, has been acknowledged for its potential to induce a rare side effect known as Thrombosis with Thrombocytopenia Syndrome (TTS). This acknowledgment coincides with a legal case alleging severe adverse effects, including fatalities, linked to the vaccine. Kate, the spouse of one affected individual, calls for an apology and just compensation after a three-year ordeal.
World Thrombosis Day: From losing weight to reducing stress, 4 ways to keep blood clots at bay
Every year, World Thrombosis Day is observed on October 13. The International Society on Thrombosis and Haemostasis has set aside this day, to create more awareness about this health condition.
Why is Deion Sanders facing possibility of getting his foot amputated? Know about his recurring health issue
Deion Sanders has been dealing with a health condition for a very long time and has reportedly gone through at least nine surgeries.
European Medicines Agency's top official links AstraZeneca vaccine and thrombosis
After several countries suspended the use of the jab -- including Italy -- the EMA declared that the benefits outweigh the risks and it should remain in use.
Alembic Pharma gets tentative USFDA nod for generic Rivaroxaban tablets
Rivaroxaban tablets are indicated for multiple conditions, including reduction of risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation; treatment of deep vein thrombosis (DVT) and treatment of pulmonary embolism (PE).
Load More
